Loading
NAV
₹35.4818
+1.40%on 6 Oct 2026
+5.22%over 1 year
Against the average of Equity Index Funds funds (direct plans, growth option). A year and longer are yearly averages.
| Period | Fund | Category average | Rank |
|---|---|---|---|
| 1 month | −3.25% | −4.41% | 47 of 259 |
| 3 months | −0.91% | −4.09% | 35 of 254 |
| 6 months | +20.41% | +6.81% | 19 of 244 |
| 1 year | +5.22% | −1.65% | 24 of 227 |
| 3 years | +13.03% | +10.80% | 39 of 96 |
| 5 years | +13.42% | +9.10% | 7 of 38 |
| 10 years | n/a | +11.01% | n/a |
₹10,000 invested on the same day every month, valued at the latest NAV.
| For | Invested | Worth now | XIRR |
|---|---|---|---|
| 1 year | ₹1.20 lakh | ₹1.28 lakh | +12.84% |
| 3 years | ₹3.60 lakh | ₹4.01 lakh | +7.10% |
| 5 years | ₹6.00 lakh | ₹8.49 lakh | +13.84% |
XIRR is the yearly return on money that went in at different times. Try your own amount and start date in the Mutual Fund Returns calculator.
The highest 3-year returns in the category, direct plans. Copy a share index, such as the Nifty 50, at a low cost.
| Fund | 1Y | 3Y | 5Y |
|---|---|---|---|
| ICICI Prudential NASDAQ 100 Index FundICICI Prudential Mutual Fund | +35.57% | +34.17% | n/a |
| Motilal Oswal S&P 500 Index FundMotilal Oswal Mutual Fund | +26.25% | +28.40% | +18.70% |
| ICICI Prudential Nifty Pharma Index FundICICI Prudential Mutual Fund | +22.03% | +20.69% | n/a |
| UTI Nifty 500 Value 50 Index FundUTI Mutual Fund | +4.26% | +19.89% | n/a |
| Edelweiss MSCI India Domestic & World Healthcare 45 Index FundEdelweiss Mutual Fund | +17.11% | +19.18% | +13.77% |
| Aditya Birla Sun Life Nifty Smallcap 50 Index FundAditya Birla Sun Life Mutual Fund | +12.99% | +17.69% | +12.52% |
A direct plan is bought from the fund house itself and costs less each year than the regular plan, which pays a distributor's commission. Growth reinvests gains; IDCW pays some out.
NAVs from AMFI; NAV history from mfapi.in, which republishes AMFI's. Returns are past returns and do not promise future ones. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. For information only, not a recommendation to invest.